B.L. Kashyap and Sons Limited (NSE:BLKASHYAP)

Market Cap	16.93B
Revenue (ttm)	11.54B
Net Income (ttm)	274.75M
Shares Out	225.44M
EPS (ttm)	1.22
PE Ratio	61.55
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,053,955
Average Volume	815,440
Open	79.90
Previous Close	79.01
Day's Range	74.15 - 79.99
52-Week Range	45.00 - 120.66
Beta	0.38
RSI	66.13
Earnings Date	Aug 12, 2025

About Theseus Pharmaceuticals

B.L. Kashyap and Sons Limited, together with its subsidiaries, engages in the construction and infrastructure development activities in India. The company constructs factories and manufacturing facilities, IT campuses, commercial and residential complexes, malls, hotels, and institutions. It undertakes engineering, procurement, and construction (EPC) projects to set up power generation plants, power transmission and distribution systems, integrated rail and metro systems, airports, hotels, residential buildings, townships, commercial buildings,...

• Industry: Engineering & Construction
• Sector: Industrials
• Founded: 1978
• Employees: 1,288
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: BLKASHYAP

Financial Performance

In 2024, B.L. Kashyap and Sons's revenue was 11.54 billion, a decrease of -7.30% compared to the previous year's 12.45 billion. Earnings were 274.75 million, a decrease of -47.70%.